Background and Aims: Owing to the global trend towards improved ‘quality of life’, there is
considerable evidence of an increase in demand for medicinal plants. The WHO guidelines …

Background Omalizumab is a recombinant humanized anti-IgE monoclonal antibody,
indicated for add-on therapy for moderate-to severe-persistent allergic (IgE-mediated) asthma. …

A 52-week, post-marketing study to assess the efficacy and safety of omalizumab in an
Indian population is ongoing; we present interim 16-week data. This is an open-label, multi-center…

Omalizumab (OMA) is an anti-IgE monoclonal antibody, indicated as add-on therapy for
moderate–to-severe persistent allergic (IgE–mediated) asthma. Here, we report the interim …

Omalizumab (OMA) is an add-on therapy for patients with moderate-to-severe allergic (IgE–mediated)
asthma, uncontrolled despite GINA step 4 therapies. Here, we report the interim …

Methods: In this open-label, non-comparative, non-interventionalstudy, patients (≥ 12 years)
with moderate-to-severe persistent allergic asthma (GINA stage 4), inadequately controlled …

Background: We designed the present study to understand the characteristics of patients
who initiate Omalizumab in a real-world setting and understand the long-term outcomes of …

… , 1946)—the story of the valiant Dr Kotnis who went to China as part of a medical team to
fight alongside the Chinese against the Japanese invasion—by V. Shantaram, Jhansi Ki Rani (…

Background and objectives: The plant Hemidesmus indicus syn. Sariba, Family-Asclepiadaceae,
is a perennial, slender, laticiferous, prostrate or semi-erect, twining, wiry shrub. Root …

ALLCHIN, FR The cultural tradition of India. Listener 69 (Mar. 28, 1963), 548-550. APPADORAI,
A. Chinese aggression and the problem of national integration. Political science review …